AEVEX, a defense technology company specializing in drones, software, and in-theater manufacturing, is positioned for significant growth with a projected 46% compound annual growth rate (CAGR) in sales and an 83% CAGR in EBITDA. The company expects to generate positive free cash flow starting this year and holds a backlog of $503.1 million alongside $8.1 billion in identified opportunities. Analyst Dhierin Bechai sets a base price target of $47.63 per share by 2028, representing a 30% upside, with an optimistic scenario reaching $67.41, reflecting its emerging premium in the defense-tech sector. Key risks include execution challenges and potential dilution, but the company's comprehensive platform and strong market debut support its growth outlook.
Barclays increased its price target for Hudbay Minerals to $32 from $30, citing strong growth prospects in copper mining. Despite a recent nearly 30% stock pullback due to market sentiment, Hudbay maintains a solid financial position with near-zero n...
Morgan Stanley reported strong Q2 2026 results, with earnings per share of $3.46 surpassing estimates of $2.89 and revenue of $21.35 billion beating forecasts of $19.67 billion. This marks significant year-over-year growth from $16.79 billion, driven...
The global autoimmune disease therapeutics market is projected to grow from $80.54 billion in 2025 to $137.85 billion by 2035, at a CAGR of 5.52%. Growth is fueled by rising autoimmune disease prevalence, advances in biologics, JAK inhibitors, monocl...
The Vancouver Chinatown Foundation and RBC are hosting Light Up Chinatown! 2026, a free two-day festival on August 8-9 along Columbia Street in Vancouver’s Chinatown. The event features exclusive food collaborations, live music performances, family a...
New research from iSeatz reveals that U.S. travelers are increasingly strategic about travel rewards programs, with 40% treating them as financial optimization tools and 60% belonging to multiple programs. Despite high enrollment, many travelers find...
